Thank you to our speakers, sponsors, and delegates who joined us in Boston for the summit! If you are interested in the 2026 event, please get in touch at info@hansonwade.com
Successfully Fast-Track Your LNPs from Concept to Market at the Largest Meeting Dedicated Purely to LNPs Worldwide
As Arbor Biotechnologies unveiled FDA approval of an IND filing for their LNP-mediated treatment for primary hyperoxaluria type 1, LNPs continued to be the hottest delivery vehicle across all payload types and completely dominated the non-viral delivery field. The promise of this delivery vehicle was truly ground-breaking!
Landing at The Westin Copley Place in Boston, the 4th LNP Formulation & Process Development Summit returned as the only industry summit dedicated to navigating LNP bottlenecks of designing novel ionizable lipids, achieving extrahepatic delivery, improving thermostability and accomplishing large scale manufacturing for advancing LNPS for a variety of applications towards patients in need.
With a revamped track design, the 2025 meeting had 3 dedicated streams Analytical Development & Characterization, Formulation & Delivery and Process Development & Manufacturing to deep dive into an end-to-end strategy for revolutionizing the discovery and development of potent, safe and stable LNPs for targeted delivery of cell therapies, gene therapies, mRNA therapeutics and beyond!
This Summit united 230+ LNP trailblazers from across the globe, and so became your one-stop-shop for LNP specific networking, partnership opportunities and collaborative discussions to further fuel advancement of LNPs towards clinical development.
Companies That Attended in April:
2025 Expert Speakers Included:
RNA/DNA Qualification in LNPs with New Scatter-Free Absorption
No dyes, no dispersions, answers in seconds
Date / time of webinar: May 7th 5pm CET, 11am EST
Intact LNP payload quantification using traditional methods is laborious, complex and time consuming. In this webinar, leading experts from 4basebio and Merck KGaA will discuss how Marama Labs’ new CloudSpec instrument enables faster formulation development by using Scatter-Free Absorption (SFA) for rapid payload quantification of intact particles – no sample dispersion or fluorescent dyes required.
Key Insights:
- Introduction to Scatter-Free Absorption (SFA) technology – a new way to quantify payloads in intact LNPs in 2 minutes analysis time per sample
- Case studies and data demonstrating quantification of RNA and antibodies in LNP formulations
- Discussion on how SFA compares with methods such as the RiboGreen assay in terms of ease of use and precision of answers
- Introduction to Marama Labs’ CloudSpec instrument and how it translates into faster development times in nanomedicine development
- Q&A session where participants can interact with industry experts, gaining deeper insights into the practical applications and potential of SFA
Why Attend:
- Gain a thorough understanding of the latest technological advancements in LNP quantification and how it can speed up your workflows in LNP development
- Hear first-hand the practical benefits and implementation of CloudSpec from industry leaders
Join us for an informative session that will provide actionable improvements in your LNP formulation development and manufacturing. Register now to secure your spot! https://register.gotowebinar.com/register/4334878914760040031
What Was New in 2025?
In addition to the unrivalled scientific content in the form of presentations, roundtable discussion, panels and workshops, there were a variety of extra experiences allowing for maximum ROI out of your time at the conference.
Refreshed Conference Streams
We strengthened this year’s conference with industry experts to ensure it remained comprehensive and highlighted the industry’s most relevant areas of interest. This year offered three parallel tracks – Analytical Development & Characterization, Formulation & Delivery and Process Development & Manufacturing - designed to optimize your LNP development
LNP 101 Day
You joined the 101 Day to equip you and your team with the essential tools and fundamental principles for successful LNP development, showcasing the full potential of LNPs across various payloads and disease areas led by the likes of AstraZeneca, Takeda, Regeneron & more.
Workshop Day
Alongside Eli Lilly & Co, AbbVie, Vertex Pharmaceuticals, Pfizer and more attendees joined the industry's biggest players as they took a deep dive into key challenges, including lipid library development, extrahepatic delivery and optimizing CMC of LNPs, accelerate novel and innovative LNPs towards the market.
What Previous Attendees of the LNP Series Had To Say:
This meeting is an excellent opportunity to connect with my counterparts in the biotech community and learn about the latest progress and challenges in advancing LNPs towards new medicinal products
Vice President, Head of Process Development, Sail Biomedicines
For professionals interested in deepening their understanding of Lipid Nanoparticles (LNPs) or seeking a comprehensive update in this field, I highly recommend attending this conference. This event will provide an invaluable overview of the current industry landscape and emerging trends in LNP technology
Scientist, Takeda Pharmaceuticals
Attending the 4th LNP Formulation & Process Development Summit provides significant value. It offers an excellent platform for engaging with experts and discussing the latest advancements in LNP technology.
Director, Non-Viral Delivery, Mammoth Biosciences
2025 Partners
Lead Partner
Expertise Partner
Program Partners
Other Events in the Series
